Archive

Adarsh Kataruka, Director, SoulAce Social Venture, talks about why each company needs to chart a CSR vision and work towards…

I had ended my last edit with the hope that this year, unlike previous years, the pharmaceutical sector’s hopes would not be as…

With a 5.7 per cent growth in sales in 2013, Boehringer Ingelheim (BI) ranks seventh among its global peers but has a long way to…

The investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines

Creates an innovative new model in speciality pharma leadership

The programme combines grants portfolio with annual €20 million investment to advance innovation and medical education

Donates 500 tubes of REGEN-D to AP CM’s Relief Fund

Telmisartan is Glenmark’s generic version of Boehringer Ingelheim’s Micardis

Receives approval from US FDA

M&A activity in the pharmaceutical sector was focused on advancing the development of promising products through complementary…